Company page

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in America, specializing in biopharmaceuticals. With a market capitalization of approximately $17.67 billion, Neurocrine focuses on developing treatments for neurological and endocrine disorders. The company is committed to advancing innovative therapies to improve patient outcomes.